\
&
Contact us
\
&
Contact us
Published on | 2 months ago
ProgrammesThe EIC Pathfinder Open 2026 call was published with incorrect settings on 05/02/2026, specifically requiring an update to the HORIZON Lump Sum Grant model.
A technical update is being carried out and it is excepted that the portal will have correct information shortly. This correction will not change the call's scope, objectives, eligibility conditions, or evaluation criteria.
However, applicants who have begun their proposals will need to restart the submission process to meet the updated call conditions. Notifications will be sent to affected applicants once the portal is corrected. Further details will be provided on the official website as they become available.
Applicants should monitor the official portal for updates and prepare to restart their submissions once notified!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
